Document |
Document Title |
WO/2009/103807A1 |
The present invention relates to copper organocomplexes and pharmaceutical compositions comprised thereof. They can be used for the treatment of illnesses caused by hyperproliferative cells, and they also protect healthy tissue from ioni...
|
WO/2009/101966A1 |
Disclosed is a metal complex containing a composition represented by the following formula (a). [(PdII)2(MI)2(X)2(L)4(L')2] (In the formula (a), MI represents AgI, AuI or CuI; X represents Cl, Br or I; L represents a group represented by...
|
WO/2009/089821A1 |
The present invention relates to transition metal complexes and to the use thereof, particularly as dopant for doping an organic semiconducting matrix material, to the organic semiconducting matrix material, and to electronic and optoele...
|
WO/2009/089310A1 |
1-Fluoro-2-substituted-3-chlorobenzenes are selectively deprotonated and functionalized in the position adjacent to the fluoro substituent.
|
WO/2009/089493A2 |
The present invention is directed to methods and compositions which include nitrate amino acid chelates that can increase the metabolic activity or metal concentration in animals and that can increase metabolic activity and nitrogen cont...
|
WO/2009/084283A1 |
A compound represented by general formula (1). In general formula (1), Y1 to Y4 each independently represent general formula (2) wherein Rα represents a hydrogen atom or a monovalent hydrocarbon group; P1 represents an atomic group whic...
|
WO/2009/080773A1 |
Described is a method for the preparation of renin inhibitors such as aliskiren, and intermediates useful therein. The method introduces a nitrogen-containing intermediate such as a lactone of formula (8). with R4 being a branched C3_6 a...
|
WO/2009/072505A1 |
Disclosed is a method for producing an organic alkali metal compound with high yield. Also disclosed is a method for producing an organic transition metal compound using the organic alkali metal compound. Specifically disclosed is a meth...
|
WO/2009/066745A1 |
Disclosed is a polynuclear complex represented by the following formula (I). (In the formula (I), M represents a group 11 metal atom or a metal ion, a represents a number of not less than 2, and a plurality of M's may be the same as or d...
|
WO/2009/056487A1 |
The present invention provides novel methods for stabilizing lithiated halogen-substituted aromatic compounds. In particular, the method is useful for the preparation of 2-methoxy-5, 6-difluorobenzaldehyde, an important intermediate for ...
|
WO/2009/054202A1 |
A method of organic-compound reaction and a process for producing an organic compound. By the method and process, high reaction selectivity and a high yield of a target substance can be ensured according to purposes. At least two fluids ...
|
WO/2009/052809A1 |
The present invention relates to Cu-(ll)-oxygen adduct complexes, which are stable at room temperature, and to methods for the production thereof. These are compounds of the general formula [L-Cu-O-O-Cu-L](BAr4)2. To this end, BAr4 is a ...
|
WO/2009/050394A2 |
The invention relates to the use of cyclovinyl phosphine compounds in the form of complexes with copper, as catalysts for reactions leading to the formation of carbon-carbon and carbon-heteroatom bonds. The invention also relates to comp...
|
WO/2009/048132A1 |
Disclosed is a compound represented by the following general formula (I). (I) In the formula (I), A and B independently represent a hydrogen atom, a halogen atom, a lithium atom, a monovalent group represented by -MgX (wherein X represen...
|
WO/2009/039216A1 |
Methods and compositions for depositing metal films are described herein. In general, the disclosed methods utilize precursor compounds comprising gold, silver or copper. More specifically, the disclosed precursor compounds utilize neutr...
|
WO/2009/035664A1 |
Fluorinated metal-organic frameworks ("FMOFs") are capable of adsorbing and desorbing gases and molecules. The FMOFs can be arranged in a variety of configurations and have internal hollow channels and cavities. In the FMOFs, hydrogen at...
|
WO/2009/030672A1 |
Process for the manufacture of a compound of formula (I) wherein R1 is H, acyl, alkyl or carbamoyl, R2 is a linear alkyl or alkenyl group, preferably a linear alkyl group comprising from 6 to 20 carbon atoms and n is 0, 1, 2, or 3, which...
|
WO/2008/145759A9 |
The present invention provides new Ag(I) complexes with derivatives of nicotinic acid, nicotinamide and related pyridine ligands, and pharmaceutical compositions comprising such Ag(I) complexes for use in the treatment, prophylaxis and p...
|
WO/2009/020225A1 |
Disclosed is a modified polymer complex produced by the intermolecular and/or intramolecular crosslinking of a polymer complex via its side chains, wherein the polymer complex is a copolymer of a complex monomer meeting the requirements ...
|
WO/2009/010129A1 |
The present invention relates to novel bispidon ligands, a method for the production thereof, and the use thereof as a ligand in metal complexes and the selective separation of metals, metal complexes comprising said ligands, method for ...
|
WO/2009/000673A2 |
Electroneutral metal complexes of the formula L Cu A, wherein L stands for an, especially bidentate, neutral ligand and A stands for an, especially bidentate, monoanionic ligand binding to Cu by at least one heteroatom selected from N, P...
|
WO/2008/150830A2 |
The invention is directed to providing a compound for treating cancer, the compound comprising a metal complex having predetermined characteristics, and which may be incorporated into a polymeric nanoparticle or other delivery system for...
|
WO2008064959B1 |
The invention relates to initiators of the general formula {[M(L)a]Xb}n, wherein these initiators preferably comprise (SbF6
|
WO/2008/142177A1 |
The compounds of the formula (I), where R1 is a radical of a lateral chain of a natural aminoacid; and R2 is a C-radical derived from one of the known 1-5 ring systems; the rings being aromatic, isolated or partly/totally fused and havin...
|
WO/2008/142652A1 |
Methods and compositions for depositing metal films are disclosed herein. In general, the disclosed methods utilize precursor compounds comprising gold, silver, or copper. More specifically, the disclosed precursor compounds utilize pent...
|
WO/2008/108407A1 |
Disclosed is a novel luminescent metal complex. Specifically disclosed is a metal complex having a composition of [(PtII)2(AuI)2(MI)2(L)8]. In the formula, MI represents AgI or CuI, and L represents a structure represented by the followi...
|
WO/2008/095646A1 |
The present invention relates to a process for lithium exchange reactions comprising mixing at least two fluids in a microreactor having at least two injection points.
|
WO/2008/092947A1 |
The present invention provides cyclopentadienyl molybdenum hexa-carbonyl complexes which can be represented by general Formula (1) which is indicated below. In this formula R1 to R10 each individually represent a group selected from the ...
|
WO/2008/075672A1 |
Disclosed is a method for producing a tris(perfluoroalkanesulfonyl)methide acid salt represented by the formula [1], which comprises a step (a) for obtaining a reaction mixture by reacting a methyl magnesium halide represented by the for...
|
WO/2008/069207A1 |
Disclosed is a lithium salt which enables to improve lithium transference number when it is used as a supporting salt of an electrolyte solution. Specifically disclosed is a lithium salt characterized by having a chemical structure repre...
|
WO/2008/066187A1 |
Disclosed is a polynuclear complex having two or more metal atoms and/or metal ions per one ligand represented by the general formula (I). (I) wherein Q1 and Q2 independently represent a bivalent heterocyclic group which may have a subst...
|
WO/2008/062958A1 |
The present invention relates to a synthesis method of metal cyclopentadienide by direct reaction of dicyclopentadiene with a group 1 metal in the presence of an aprotic solvent. Unlike the conventional method depending on retro Diels -A...
|
WO/2008/053976A1 |
A novel luminescent metal complex. The metal complex has a composition of the formula [(PtII)2(MI)2(X)2(L)4(LH)2]. MI is AgI, AuI or CuI; X is Cl, Br or I; L is the structure of the formula (1); and LH is the structure of the formula (2).
|
WO/2008/050733A1 |
Disclosed are: a gold complex represented by the general formula (1); a method for producing the gold complex; and an organic ultraviolet electroluminescent element using the gold complex. (1) wherein L represents a nitrogenated heterocy...
|
WO/2008/050661A1 |
Disclosed is a method for producing an asymmetric copper complex crystal wherein a crystallization process is performed in the presence of an alcohol solvent after reacting an optically active salicylideneaminoalcohol compound with a cop...
|
WO/2008/048351A2 |
Embodiments of the present subject matter provide a compound and material that may be used as a lead-free primary explosive. An embodiment of the present subject matter provides the compound copper(I) nitrotetrazolate. Certain embodiment...
|
WO/2008/040397A1 |
The present invention concerns a new molecule, 64-copper(II)asparagine, that in the PET diagnostic method allows a double use in "vivo": a diagnostic use and a radiotherapeutic use.
|
WO/2008/035533A1 |
Disclosed is an optical filer having excellent weather resistance, which enables good color reproducibility regardless of emission wavelength change in a light-emitting device due to use environment a color image display, in particular t...
|
WO/2008/032793A1 |
Disclosed is a lithium salt having excellent ion conductivity. Specifically disclosed is a lithium salt characterized by having a structure represented by the following general formula (1). (In the general formula (1), M represents B, Si...
|
WO/2008/029804A1 |
Disclosed is a perchloric acid ion trapping agent containing a heterocyclic substituted aromatic compound represented by the general formula (I) below. In the general formula (I) below, one of R2, R3 and R4 represents an Ry at the meta- ...
|
WO/2008/020218A1 |
Disclosed are metal organic frameworks that adsorb nitric oxide, NO-loaded metal organic frameworks, methods of preparing the NO-loaded metal organic frameworks, methods of releasing the nitric oxide into a solution or into air, and uses...
|
WO/2008/019091A1 |
A dietary source of mineral in the form of a metal carboxylate is prepared using the acid-base-like reaction. A salt of a carboxylate anion and a by-product cation is reacted in aqueous solution with a salt of a metal cation and a by-pro...
|
WO/2008/018861A1 |
The present invention relates to novel 1,3-diimine copper complexes and the use of 1,3-diimine copper complexes for the deposition of copper on substrates or in or on porous solids in an Atomic Layer Deposition process.
|
WO/2008/017514A1 |
The present invention relates to a method of producing an adsorbent comprising hydrophilic and porous metal-organic framework (MOF) structures. This adsorbent finds use in heat stores or heat pumps.
|
WO2006136564A9 |
Compounds of general formula (I): in which: R1, R2, R3, R4, R5 and FG are as defined in the specification and claims, optionally conjugated with a suitable molecule able to interact with physiological systems; and their chelates with bi-...
|
WO/2008/012216A1 |
The present invention relates to methods for producing a porous, organometallic framework material containing a first and at least one second at least bidentate organic compound coordinatively bound to at least one copper ion, including ...
|
WO/2007/142132A1 |
Disclosed is a novel production process which can produce a compound between a porphyrin (Y) and a polyvalent metal in a large quantity. The process comprises the following steps (1) and (2): (1) preparing an alkali metal-containing basi...
|
WO/2007/142700A1 |
Copper (I) amidinate and copper (I) guanidinate precursors for forming copper thin films in the manufacture of microelectronic device articles, e.g., using chemical vapor deposition, atomic layer deposition, and rapid vapor deposition pr...
|
WO/2007/141662A2 |
An amidine-carboxylic acid complex in accordance with an aspect of the invention has an amidine ligand and a carboxylic acid ligand that are coordinated to one metal atom or a plurality of metal atoms of the same element. A multiple-comp...
|
WO/2007/139001A1 |
A substituted phenylethynyl gold-nitrogenated heterocyclic carbene complex represented by the general formula (1) or (2): (1) (2) wherein L represents a nitrogenated heterocyclic carbene ligand; and X represents an alkyl group, a cycloal...
|